MRVI logo

MRVI Stock Overview

Profile

Full Name:

Maravai LifeSciences Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 20, 2020

Indexes:

Not included

Description:

Maravai LifeSciences Holdings is a biotechnology company that provides essential products and services for the development of vaccines and therapies. They specialize in nucleic acid production, offering tools for research and manufacturing to support the life sciences industry.

Key Details

Price

$4.87

Annual Revenue

$288.94 M(-67.28% YoY)

Annual EPS

-$0.90(-153.89% YoY)

Annual ROE

-14.04%

Beta

0.82

Events Calendar

Earnings

Next earnings date:

Feb 25, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 22, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 5, 24 Goldman Sachs
Sell
Nov 14, 24 Wolfe Research
Peer Perform
Nov 8, 24 William Blair
Market Perform
Nov 8, 24 RBC Capital
Outperform
Nov 8, 24 Baird
Outperform
Oct 8, 24 Goldman Sachs
Neutral
Aug 27, 24 Wells Fargo
Overweight
Aug 16, 24 RBC Capital
Outperform
Aug 13, 24 Morgan Stanley
Equal-Weight
Aug 8, 24 UBS
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
MRVI
globenewswire.comJanuary 8, 2025

SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that based on preliminary year-end results and subject to year-end closing adjustments, the Company expects to report total 2024 revenue near the mid-point of the previously announced guidance range of $255.0 million and $265.0 million. The Company also announced that it plans to announce its fourth quarter and full year 2024 financial and operating results after the market closes on Tuesday, February 25, 2025, and will host a conference call and webcast on the same day at 2:00 p.m.

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
MRVI
globenewswire.comDecember 5, 2024

SAN DIEGO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that Carl Hull will retire from his position as Executive Chairman of the Board and that the Board of Directors has unanimously elected R. Andrew Eckert to succeed him as Chairman of the Board, effective December 5, 2024.

Maravai LifeSciences Announces November 2024 Investor Conference Schedule
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
MRVI
globenewswire.comNovember 12, 2024

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences in November.

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call Transcript
MRVI
seekingalpha.comNovember 9, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Deb Hart - Head, Investor Relations Trey Martin - Chief Executive Officer Kevin Herde - EVP and Chief Financial Officer Drew Burch - President, Nucleic Acid Production Conference Call Participants Dan Leonard - UBS Justin Bowers - Deutsche Bank Yuko Oku - Morgan Stanley Matt Hewitt - Craig-Hallum Dan Arias - Stifel Operator Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
MRVI
globenewswire.comOctober 15, 2024

SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2024 financial and operating results after the market closes on Thursday, November 7, 2024, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
MRVI
globenewswire.comAugust 12, 2024

SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences in August and September.

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
MRVI
globenewswire.comJuly 10, 2024

SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on Wednesday, August 7, 2024, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

Maravai (MRVI) Advances in RNA Research With New Collaboration
Maravai (MRVI) Advances in RNA Research With New Collaboration
Maravai (MRVI) Advances in RNA Research With New Collaboration
MRVI
zacks.comMay 17, 2024

According to management at Per Maravai LifeSciences (MRVI), this advancement by TriLink is poised to enhance nucleic acid-based therapies.

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2023 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2023 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2023 Earnings Call Transcript
MRVI
Seeking AlphaNovember 8, 2023

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Deb Hart - Investor Relations Trey Martin - Chief Executive Officer Kevin Herde - Chief Financial Officer Drew Burch - President, Nucleic Acid Production Becky Buzzeo - Executive Vice President and Chief Commercial Officer Conference Call Participants Tejas Savant - Morgan Stanley Tom Peterson - Baird Matt Larew - William Blair Michael Ryskin - Bank of America Conor McNamara - RBC Capital Markets Dan Arias - Stifel Justin Bowers - Deutsche Bank Operator Ladies and gentlemen, thank you for standing by. My name is Tammy and I will be your conference operator today.

Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023
MRVI
GlobeNewsWireOctober 17, 2023

SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2023 financial and operating results after the market closes on Tuesday, November 7, 2023, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the ticker symbol for Maravai LifeSciences Holdings?
  • Does Maravai LifeSciences Holdings pay dividends?
  • What sector is Maravai LifeSciences Holdings in?
  • What industry is Maravai LifeSciences Holdings in?
  • What country is Maravai LifeSciences Holdings based in?
  • When did Maravai LifeSciences Holdings go public?
  • Is Maravai LifeSciences Holdings in the S&P 500?
  • Is Maravai LifeSciences Holdings in the NASDAQ 100?
  • Is Maravai LifeSciences Holdings in the Dow Jones?
  • When was Maravai LifeSciences Holdings's last earnings report?
  • When does Maravai LifeSciences Holdings report earnings?
  • Should I buy Maravai LifeSciences Holdings stock now?

What is the ticker symbol for Maravai LifeSciences Holdings?

The ticker symbol for Maravai LifeSciences Holdings is NASDAQ:MRVI

Does Maravai LifeSciences Holdings pay dividends?

No, Maravai LifeSciences Holdings does not pay dividends

What sector is Maravai LifeSciences Holdings in?

Maravai LifeSciences Holdings is in the Healthcare sector

What industry is Maravai LifeSciences Holdings in?

Maravai LifeSciences Holdings is in the Biotechnology industry

What country is Maravai LifeSciences Holdings based in?

Maravai LifeSciences Holdings is headquartered in United States

When did Maravai LifeSciences Holdings go public?

Maravai LifeSciences Holdings's initial public offering (IPO) was on November 20, 2020

Is Maravai LifeSciences Holdings in the S&P 500?

No, Maravai LifeSciences Holdings is not included in the S&P 500 index

Is Maravai LifeSciences Holdings in the NASDAQ 100?

No, Maravai LifeSciences Holdings is not included in the NASDAQ 100 index

Is Maravai LifeSciences Holdings in the Dow Jones?

No, Maravai LifeSciences Holdings is not included in the Dow Jones index

When was Maravai LifeSciences Holdings's last earnings report?

Maravai LifeSciences Holdings's most recent earnings report was on Nov 7, 2024

When does Maravai LifeSciences Holdings report earnings?

The next expected earnings date for Maravai LifeSciences Holdings is Feb 25, 2025

Should I buy Maravai LifeSciences Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions